Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study

More than a quarter of those with MASLD-related HCC without cirrhosis have a low FIB-4. The proposed clinical care pathways may not identify these people for further evaluation.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2024-10-27
DOI
https://doi.org/10.1111/apt.18346
Citations
17
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
6.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study

Karn Wijarnpreecha, Daniel Q. Huang, Darren Jun Hao Tan, Rohit S. Loomba et al.
17 citations
Alimentary Pharmacology & Therapeutics
Liver Disease Diagnosis and Treatment
6.57
article

Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study

Karn Wijarnpreecha, Daniel Q. Huang, Darren Jun Hao Tan, Rohit S. Loomba, Nobuharu Tamaki, Shirin Salimi, Benjamin Tay, Majd B. Aboona, John Mok, Anand Vijay Kulkarni, Mark Dhinesh Muthiah, Benjamin Nah, Pojsakorn Danpanichkul, Claire Faulkner, Cheng Han Ng, Abdul‐Hamid Sabih, Charlotte Kench, Sung Won Lee, Beom Kyung Kim, Ken Liu, Y. Teh, Wen Hui Lim
article en
17 citations

Abstract

More than a quarter of those with MASLD-related HCC without cirrhosis have a low FIB-4. The proposed clinical care pathways may not identify these people for further evaluation.

Alimentary Pharmacology & TherapeuticsVol. 61(2)
Texas Tech University (US), University of Arizona (US), National University of Singapore (SG), Yonsei University (KR), Royal Prince Alfred Hospital (AU), University of California San Diego (US), Asian Institute of Gastroenterology (IN), National University Hospital (SG), Musashino Red Cross Hospital (JP), Catholic University of Korea (KR), Texas Tech University Health Sciences Center (US)
National University Health System, Medical Research Council, National Medical Research Council, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 3%
Liver Disease Diagnosis and Treatment
6.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.